Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.

McIlroy SP, Crawford VL, Dynan KB, McGleenon BM, Vahidassr MD, Lawson JT, Passmore AP.

J Med Genet. 2000 Mar;37(3):182-5.

2.

Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.

Raygani AV, Zahrai M, Soltanzadeh A, Doosti M, Javadi E, Pourmotabbed T.

Neurosci Lett. 2004 Nov 23;371(2-3):142-6.

PMID:
15519745
3.

No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.

Ki CS, Na DL, Kim JW, Kim HJ, Kim DK, Yoon BK.

Am J Med Genet. 1999 Apr 16;88(2):113-5.

PMID:
10206226
4.

Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.

Wiebusch H, Poirier J, Sévigny P, Schappert K.

Hum Genet. 1999 Feb;104(2):158-63.

PMID:
10190327
5.
6.

Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients.

Hiltunen M, Mannermaa A, Helisalmi S, Koivisto A, Lehtovirta M, Ryynänen M, Riekkinen P Sr, Soininen H.

Neurosci Lett. 1998 Jun 26;250(1):69-71.

PMID:
9696068
7.

No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.

Singleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA, Morris CM.

Hum Mol Genet. 1998 May;7(5):937-9.

PMID:
9536100
8.

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

Kehoe PG, Williams H, Holmans P, Wilcock G, Cairns NJ, Neal J, Owen MJ.

J Med Genet. 1998 Dec;35(12):1034-5.

9.

Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.

Tilley L, Morgan K, Grainger J, Marsters P, Morgan L, Lowe J, Xuereb J, Wischik C, Harrington C, Kalsheker N.

Eur J Hum Genet. 1999 Sep;7(6):659-63.

10.

The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.

Alvarez-Arcaya A, Combarros O, Llorca J, Sánchez-Guerra M, Berciano J, Fernández-Viadero C, Peña N.

Acta Neurol Scand. 2000 Dec;102(6):350-3.

PMID:
11125748
11.

Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.

Nassar BA, Darvesh S, Bevin LD, Rockwood K, Kirkland SA, O'Neill BJ, Bata IR, Johnstone DE, Title LM.

Clin Biochem. 2002 May;35(3):205-9.

PMID:
12074828
12.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
13.

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.

Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.

Pharmacogenet Genomics. 2008 Apr;18(4):289-98. doi: 10.1097/FPC.0b013e3282f63f29.

PMID:
18334913
14.

Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland.

McIlroy SP, Vahidassr MD, Savage DA, Patterson CC, Lawson JT, Passmore AP.

Am J Med Genet. 1999 Apr 16;88(2):140-4.

PMID:
10206233
15.
16.

Butyrycholinesterase K variant and Alzheimer's disease.

Panegyres PK, Mamotte CD, Vasikaran SD, Wilton S, Fabian V, Kakulas BA.

J Neurol. 1999 May;246(5):369-70.

PMID:
10399868
17.

Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease.

Brindle N, Song Y, Rogaeva E, Premkumar S, Levesque G, Yu G, Ikeda M, Nishimura M, Paterson A, Sorbi S, Duara R, Farrer L, St George-Hyslop P.

Hum Mol Genet. 1998 May;7(5):933-5.

PMID:
9536099
18.

Improved prediction of early-onset coronary artery disease using APOE epsilon4, BChE-K, PPARgamma2 Pro12 and ENOS T-786C in a polygenic model.

Nassar BA, Rockwood K, Kirkland SA, Ransom TP, Darvesh S, MacPherson K, Johnstone DE, O'Neill BJ, Bata IR, Andreou P, Jeffery JS, Cox JL, Title LM.

Clin Biochem. 2006 Feb;39(2):109-14. Epub 2005 Nov 18.

PMID:
16298355
19.

Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample.

Piccardi M, Congiu D, Squassina A, Manconi F, Putzu PF, Mereu RM, Chillotti C, Del Zompo M.

Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):895-9.

PMID:
17503475
20.

Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).

Déniz-Naranjo MC, Muñoz-Fernández C, Alemany-Rodríguez MJ, del Carmen Pérez-Vieitez M, Aladro-Benito Y, Irurita-Latasa J, Sánchez-García F.

Neurosci Lett. 2007 Oct 29;427(1):34-8. Epub 2007 Sep 4.

PMID:
17923322

Supplemental Content

Support Center